Analyst Coverage

Firm Analyst
Barclays Douglas Tsao
BMO Capital Markets Gary Nachman
BTIG Timothy Chiang
Canaccord Genuity Neil Maruoka
CIBC World Markets Inc. Prakash Gawd
Deutsche Bank Research Gregg Gilbert
Evercore ISI Umer Raffat
Guggenheim Securities LLC Louise Chen
Jefferies & Co. David Steinberg
J.P. Morgan Christopher Schott
Mizuho Securities Irina R. Koffler
Morgan Stanley David Risinger
Piper Jaffray & Co David Amsellem
RBC Capital Markets (Canada) Douglas Miehm
Rodman&Renshaw Raghuram Selvaraju
Scotiabank Alan Ridgeway
Stifel, Nicolaus & Company, Inc Annabel Samimy
Susquehanna Financial Group Andrew Finkelstein
TD Securities Lennox Gibbs
Wells Fargo David Maris

Valeant Pharmaceuticals International, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Valeant Pharmaceuticals International, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Valeant Pharmaceuticals International, Inc. or its management. Valeant Pharmaceuticals International, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.